Cargando…
Low Helicobacter pylori primary resistance to clarithromycin in gastric biopsy specimens from dyspeptic patients of a city in the interior of São Paulo, Brazil
BACKGROUND: Clarithromycin, amoxicillin, and a pump proton inhibitor are the most common drugs recommended as first-line triple therapy for H.pylori treatment, which results in eradication rates close to 80%, varying regionally, principally due to emergency cases and increases of clarithromycin resi...
Autores principales: | Suzuki, Rodrigo Buzinaro, Lopes, Rodrigo Augusto Basso, da Câmara Lopes, George Arouche, Hung Ho, Tin, Sperança, Márcia Aparecida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235177/ https://www.ncbi.nlm.nih.gov/pubmed/24305035 http://dx.doi.org/10.1186/1471-230X-13-164 |
Ejemplares similares
-
Absence of Helicobacter pylori high tetracycline resistant 16S rDNA AGA926-928TTC genotype in gastric biopsy specimens from dyspeptic patients of a city in the interior of São Paulo, Brazil
por: Suzuki, Rodrigo Buzinaro, et al.
Publicado: (2012) -
Spatio-temporal distribution of human American visceral leishmaniasis in the Western region of Sao Paulo State, from 2004 to 2018
por: Rancan, Eduardo Alexandre, et al.
Publicado: (2020) -
Helicobacter pylori Mutations Conferring Resistance to Fluoroquinolones and Clarithromycin among Dyspeptic Patients Attending a Tertiary Hospital, Tanzania
por: Jaka, Hyasinta, et al.
Publicado: (2019) -
Evaluation of diagnostic methods for the detection of Helicobacter pylori in gastric biopsy specimens of dyspeptic patients
por: Ramis, Ivy Bastos, et al.
Publicado: (2012) -
High Frequency of A2143G Mutation in Clarithromycin-Resistant Helicobacter pylori Isolates Recovered from Dyspeptic Patients in Iran
por: Abadi, Amin T., et al.
Publicado: (2011)